Senate2025-26 sessionFiscal note

SSB 5240 — Concerning anaphylaxis medications in schools.

Did not pass — the 2025–26 session has ended

Sponsor
Wellman
Introduced
February 11, 2025
Status
S Rules 3
Last action
By resolution, returned to Senate Rules Committee for third reading. (March 12, 2026)

What this bill does

Allows a school nurse or designated trained school personnel to use any available epinephrine on school property to respond to an anaphylactic reaction when certain requirements are met. Requires the school district or school to reimburse the cost of the epinephrine to the owner if it is not school-owned epinephrine and not owned by the individual who received the epinephrine. Adds civil and criminal liability protections when epinephrine is administered by a school nurse or other employee in substantial compliance with the written policies of the school district if they are aligned with a standing protocol.

From the Washington State Legislature's nonpartisan staff bill analysis. Read the full analysis ↗

Floor votes

  • Senate — 3rd Reading & Final Passage · March 10, 2025
    49 yea · 0 nay
  • Senate — Final Passage · January 21, 2026
    49 yea · 0 nay

Track SSB 5240 on OlympiaTrack

A free account adds a plain-English AI summary, the full hearing and amendment record, who testified, and roll calls by member. Track the subject and get an alert if it comes back next session.

Create a free account

Other bills sponsored by Wellman

All 2025-26 Washington State bills →

Source: the Washington State Legislature. OlympiaTrack is an independent bill-tracking service and is not affiliated with the Legislature. View on leg.wa.gov ↗